Winfield Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $5.1M | Sell |
|
|||||
|
2021
Q3 | $5.97M | Sell |
|
|||||
|
2021
Q2 | $6.45M | Buy |
|
|||||
|
2021
Q1 | $6.39M | Buy |
|
|||||
|
2020
Q4 | $6.34M | Buy |
|
|||||
|
2020
Q3 | $4.34M | Buy |
|
|||||
|
2020
Q2 | $3.23M | Buy |
|
|||||
|
2020
Q1 | $2.2M | Sell |
|
|||||
|
2019
Q4 | $3.14M | Sell |
|
|||||
|
2019
Q3 | $2.69M | Sell |
|
|||||
|
2019
Q2 | $3.2M | Buy |
|
|||||
|
2019
Q1 | $3.23M | Buy |
|
|||||
|
2018
Q4 | $2.1M | Sell |
|
|||||
|
2018
Q3 | $3.34M | Buy |
|
|||||
|
2018
Q2 | $2.8M | Buy |
|
|||||
|
2018
Q1 | $2.11M | Buy |
|
|||||
|
2017
Q4 | $1.42M | Buy |
|
|||||
|
2017
Q3 | $865K | Buy |
|
|||||
|
2017
Q2 | $558K | Buy |
|
|||||
|
2017
Q1 | $183K | Buy |
|